TerminatedISRCTN42386710
A double blind placebo controlled discontinuation of citalopram in adolescents with major depression
This study ended early.
In CanadaDepressionResearch studyAges 13–18
Mental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedACTRN12607000286448
A double blind control study on the effects of mirtazapine during the acute withdrawal in patients attending a cannabis dependency program with focus on anxiety, depression and sleep disturbances.
Official study title
A double blind randomised control trial on the effects of mirtazapine during the acute withdrawal in patients attending a cannabis dependency program with focus on anxiety, depression and sleep disturbances.
This study has finished and is no longer accepting participants.
Location not clearly listedDepression, AnxietyInterventional studyAges 16–69
CompletedACTRN12607000074493
A double blind placebo controlled study of NAC in Bipolarity.
Official study title
An investigation of the effects of n-acetyl cysteine in bipolar disorder based on time to intervention for mood symptoms and a range of psychiatric rating scales.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityInterventional studyAges 18+
CompletedNCT00481026
A Double Blind Sham Controlled study of tDCS in Treating Schizophrenia and Depression
Official study title
A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression
This study has finished and is no longer accepting participants.
In PrahranDepression, SchizophreniaDevice studyAges 18–75
TerminatedNCT00584688
A Double Blind, Placebo Controlled study of Quetiapine in Eating disorders, a Dual Site Study
Official study title
A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study
This study ended early.
In TampaEating disordersMedication studyAges 18–65
CompletedEUCTR 2006-001475-38
A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In NetherlandsAnxiety, DepressionHistorical research record
CompletedEUCTR 2006-003659-19
A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiet...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomAnxiety, DepressionHistorical research record
CompletedEUCTR 2020-003469-20
A double blind, randomized, placebo-controlled, adaptive 14-week Phase IIb trial to evaluate the efficacy and safety of vafidemstat in an adult borderline personality disorder (BPD) population (PORTICO)
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaPersonality disordersHistorical research record
CompletedNCT00686140
A and study of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia
Official study title
Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in First-Episode and Drug-naive Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–65
CompletedNCT00181571
A Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Official study title
A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In CambridgeADHDMedication studyAges 18–55
CompletedNCT00181675
A Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Official study title
A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In CambridgeADHDMedication studyAges 18–58
TerminatedNCT01721330
A Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Official study title
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
This study ended early.
In CambridgeADHDMedication studyAges 18–55
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.